GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects

Melanie Sulistio, Curtis Carothers, Mandeep Mangat, Mike Lujan, Rene Oliveros, Robert Chilton

Research output: Contribution to journalArticle

23 Scopus citations

Fingerprint Dive into the research topics of 'GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects'. Together they form a unique fingerprint.

Medicine & Life Sciences